222

HANA PHARM

No trades
See on Supercharts
Market capitalization
‪227.66 B‬KRW
‪22.33 B‬KRW
‪224.46 B‬KRW
‪6.38 M‬
Beta (1Y)
0.39

About HANA PHARM

CEO
Tae-Hong Choi
Headquarters
Hwaseong-si
Employees (FY)
707
Founded
1978
ISIN
KR7293480000
FIGI
BBG00LSC4127
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. Its products include medicines in the form of tablets, capsules, liquid injections, polypropylene ampoule injections, freeze-dried and non-sterile Vial injections, pre-filled syringe injections, and liquid suction. The company was founded on January 19, 1978 and is headquartered in Hwaseong-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 293480 is 13240 KRW — it has decreased by 0.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANA PHARM stocks are traded under the ticker 293480.
293480 stock is 1.60% volatile and has beta coefficient of 0.39. Check out the list of the most volatile stocks — is HANA PHARM there?
HANA PHARM revenue for the last quarter amounts to ‪41.80 B‬ KRW despite the estimated figure of ‪43.50 B‬ KRW. In the next quarter revenue is expected to reach ‪56.60 B‬ KRW.
Yes, you can track HANA PHARM financials in yearly and quarterly reports right on TradingView.
293480 stock has fallen by 0.45% compared to the previous week, the month change is a 3.50% fall, over the last year HANA PHARM has showed a 13.24% decrease.
293480 net income for the last quarter is ‪5.49 B‬ KRW, while the quarter before that showed ‪3.83 B‬ KRW of net income which accounts for 43.40% change. Track more HANA PHARM financial stats to get the full picture.
Today HANA PHARM has the market capitalization of ‪229.56 B‬, it has decreased by 3.12% over the last week.
Yes, 293480 dividends are paid annually. The last dividend per share was 510.00 KRW. As of today, Dividend Yield (TTM)% is 3.84%. Tracking HANA PHARM dividends might help you take more informed decisions.
HANA PHARM dividend yield was 3.66% in 2023, and payout ratio reached 39.51%. The year before the numbers were 2.79% and 36.30% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 293480 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANA PHARM stock right from TradingView charts — choose your broker and connect to your account.
293480 reached its all-time high on Oct 2, 2018 with the price of 34950 KRW, and its all-time low was 13170 KRW and was reached on Apr 11, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 707.00 employees. See our rating of the largest employees — is HANA PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANA PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANA PHARM stock shows the sell signal. See more of HANA PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANA PHARM EBITDA is ‪33.67 B‬ KRW, and current EBITDA margin is 15.02%. See more stats in HANA PHARM financial statements.